Table 3.
Correlation analysis between nailfold videocapillaroscopy findings and sarcoidosis patients’ clinical and instrumental features
| ρs (P- value) | |||
|---|---|---|---|
| Mean absolute capillary count | Dilations | Neoangiogenesis | |
| ACE% | 0.20 (0.325) | – 0.40 (0.045) | – 0.02 (0.911) |
| FEV1% | 0.34 (0.367) | 0.13 (0.444) | – 0.13 (0.792) |
| FVC% | 0.40 (0.041) | 0.18 (0.39) | – 0.36 (0.061) |
| TLC% | 0.28 (0.185) | – 0.05 (0.807) | 0.08 (0.707) |
| DLCO% | 0.45 (0.068) | 0.36 (0.081) | – 0.01 (0.946) |
| Disease duration | – 0.17 (0.402) | – 0.25 (0.221) | 0.35 (0.077) |
| Scadding Staging System | 0.01 (0.974) | – 0.11 (0.593) | – 0.06 (0.77) |
| SUVmax | – 0.11 (0.583) | 0.02 (0.91) | – 0.08 (0.712) |
Values in bold are statistically significant (p < 0.05)
ρs Spearman’s rho, ACE angiotensin converting enzyme, DLCO% percent predicted diffusing lung capacity of carbon monoxide (CO), FEV1% percent predicted forced expiratory volume in 1 s, FVC% percent predicted forced vital capacity, SUVmax maximum standard uptake volume, TLC% percent predicted total lung capacity